BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37378837)

  • 21. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cell‑derived microenvironment through the MAPK/ERK and NF-κB pathways.
    Wang J; Weng Y; Zhang M; Li Y; Fan M; Guo Y; Sun Y; Li W; Shi Q
    Oncol Rep; 2016 Jul; 36(1):410-8. PubMed ID: 27177272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway.
    Li S; Zhou G; Liu W; Ye J; Yuan F; Zhang Z
    Oncol Res; 2021 Sep; 28(7):685-700. PubMed ID: 32886059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways.
    Jin X; Li Y; Yang Y; Shen H; Chen J; Xu B; Xu J
    J Orthop Surg Res; 2022 Jan; 17(1):53. PubMed ID: 35093114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EGFL6 promotes breast cancer by simultaneously enhancing cancer cell metastasis and stimulating tumor angiogenesis.
    An J; Du Y; Fan X; Wang Y; Ivan C; Zhang XG; Sood AK; An Z; Zhang N
    Oncogene; 2019 Mar; 38(12):2123-2134. PubMed ID: 30455428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging role of EGFL6 in angiogenesis and tumor progression.
    Kang J; Wang J; Tian J; Shi R; Jia H; Wang Y
    Int J Med Sci; 2020; 17(10):1320-1326. PubMed ID: 32624687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CaSR Induces Osteoclast Differentiation and Promotes Bone Metastasis in Lung Adenocarcinoma.
    Liu L; Fan Y; Chen Z; Zhang Y; Yu J
    Front Oncol; 2020; 10():305. PubMed ID: 32269963
    [No Abstract]   [Full Text] [Related]  

  • 28. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment.
    Zhang L; Liu M; Liu J; Li X; Yang M; Su B; Lin Y
    J Cell Physiol; 2019 Aug; 234(8):12692-12700. PubMed ID: 30511368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
    Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPON2 promotes the bone metastasis of lung adenocarcinoma via activation of the NF-κB signaling pathway.
    Wu M; Kong D; Zhang Y
    Bone; 2023 Feb; 167():116630. PubMed ID: 36427776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Water extract of the fruits of Alpinia oxyphylla inhibits osteoclast differentiation and bone loss.
    Ha H; Shim KS; Kim T; Lee CJ; Park JH; Kim HS; Ma JY
    BMC Complement Altern Med; 2014 Sep; 14():352. PubMed ID: 25249312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
    Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
    Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
    Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
    Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma 
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].
    Wu A; Li M; Mai Z; Li S; Yang Z
    Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):233-238. PubMed ID: 28442011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
    Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
    Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
    Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
    Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH
    Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Xuan YW; Liao M; Zhai WL; Peng LJ; Tang Y
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8411-8421. PubMed ID: 31646571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.